• 1
    Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant. 2005;24(8):945955.
  • 2
    Redfield MM, Gersh BJ, Bailey KR, et al. Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol. 1993;22(7):19211926.
  • 3
    Cooper L, Virmani R, Chapman N, et al. National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc. 2006;81(2):199204.
  • 4
    Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107(22):27932798.
  • 5
    Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42(3):466472.
  • 6
    Caforio AL, Mahon NG, Tona F, et al. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail. 2002;4(4):411417.
  • 7
    Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104(1):3945.
  • 8
    Fairweather D, Kaya Z, Shellam GR, et al. From infection to autoimmunity. J Autoimmun. 2001;16(3):175186.
  • 9
    Horwitz MS, La Cava A, Fine C, et al. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med. 2000;6(6):693697.
  • 10
    Ratcliffe HE, Swanson GM, Fischer LJ. Human exposure to mercury: a critical assessment of the evidence of adverse health effects. J Toxicol Environ Health. 1996;49(3):221270.
  • 11
    Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18(2):321336.
  • 12
    Bulat P, Dujic I, Potkonjak B, et al. Activity of glutathione peroxidase and superoxide dismutase in workers occupationally exposed to mercury. Int Arch Occup Environ Health. 1998;71(suppl):S37S39.
  • 13
    Frustaci A, Magnavita N, Chimenti C, et al. Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. J Am Coll Cardiol. 1999;33(6):15781583.
  • 14
    Koller LD. Methylmercury: effect on oncogenic and nononcogenic viruses in mice. Am J Vet Res. 1975;36(10):15011504.
  • 15
    Christensen MM, Ellermann-Eriksen S, Rungby J, et al. Influence of mercuric chloride on resistance to generalized infection with herpes simplex virus type 2 in mice. Toxicology. 1996;114(1):5766.
  • 16
    South PK, Morris VC, Levander OA, et al. Mortality in mice infected with an amyocarditic coxsackievirus and given a subacute dose of mercuric chloride. J Toxicol Environ Health A. 2001;63(7):511523.
  • 17
    Ilback NG, Lindh U, Wesslen L, et al. Trace element distribution in heart tissue sections studied by nuclear microscopy is changed in Coxsackie virus B3 myocarditis in methyl mercury-exposed mice. Biol Trace Elem Res. 2000;78(1–3):131147.
  • 18
    Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980;101(2):425484.
  • 19
    Gainer JH. Effects of heavy metals and of deficiency of zinc on mortality rates in mice infected with encephalomyocarditis virus. Am J Vet Res. 1977;38(6):869872.
  • 20
    Toyama I, Kolmer JA. The influence of arsphenamine and mercuric chloride upon complement and antibody production. J Immunol. 1918;3:301316.
  • 21
    Webb JL. Mercurials. In: WebbJL, ed. Enzyme and Metabolic Inhibitors. New York, NY: Academic Press; 1966:729985.
  • 22
    Beck MA, Levander OA, Handy J. Selenium deficiency and viral infection. J Nutr. 2003;133(5)(suppl 1):1463S1467S.
  • 23
    Ilback NG, Lindh U, Fohlman J, et al. New aspects of murine coxsackie B3 myocarditis-focus on heavy metals. Eur Heart J. 1995;16(suppl O):2024.
  • 24
    Ilback NG, Wesslen L, Fohlman J, et al. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis). Toxicol Lett. 1996;89(1):1928.
  • 25
    Nielsen JB, Hultman P. Mercury-induced autoimmunity in mice. Environ Health Perspect. 2002;110(suppl 5):877881.
  • 26
    Johansson U, Sander B, Hultman P. Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun. 1997;10(4):347355.
  • 27
    Johansson U, Hansson-Georgiadis H, Hultman P. The genotype determines the B cell response in mercury-treated mice. Int Arch Allergy Immunol. 1998;116(4):295305.
  • 28
    Yang JM, Baserga SJ, Turley SJ, et al. Fibrillarin and other snoRNP proteins are targets of autoantibodies in xenobiotic-induced autoimmunity. Clin Immunol. 2001;101(1):3850.
  • 29
    Pollard KM, Pearson DL, Bluthner M, et al. Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J Immunol. 2000;165(4):22632270.
  • 30
    Kubicka-Muranyi M, Kremer J, Rottmann N, et al. Murine systemic autoimmune disease induced by mercuric chloride: T helper cells reacting to self proteins. Int Arch Allergy Immunol. 1996;109(1):1120.
  • 31
    Holmgren A, Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995;252:199208.
  • 32
    Bjornstedt M, Kumar S, Bjorkhem L, et al. Selenium and the thioredoxin and glutaredoxin systems. Biomed Environ Sci. 1997;10(2–3):271279.
  • 33
    Williams CH, Arscott LD, Muller S, et al. Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem. 2000;267(20):61106117.
  • 34
    Blum H, Rollinghoff M, Gessner A. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF). Cytokine. 1996;8(1):613.
  • 35
    Schenk H, Vogt M, Droge W, et al. Thioredoxin as a potent costimulus of cytokine expression. J Immunol. 1996;156(2):765771.
  • 36
    Yamauchi A, Masutani H, Tagaya Y, et al. Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent. Mol Immunol. 1992;29(2):263270.
  • 37
    Biguet C, Wakasugi N, Mishal Z, et al. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem. 1994;269(46):2886528870.
  • 38
    Bertini R, Howard OM, Dong HF, et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med. 1999;189(11):17831789.
  • 39
    Rayman MP. The importance of selenium to human health. Lancet. 2000;356(9225):233241.
  • 40
    Moller-Madsen B. Localization of mercury in CNS of the rat. An autometallographic study. Pharmacol Toxicol. 1994;75(suppl 1):141.
  • 41
    Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645655.
  • 42
    Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol. 2003;38(2):232242.
  • 43
    United States Department of Agriculture, Agricultural Research Service. Nutrient Data Laboratory Web site. Accessed March 23, 2007.
  • 44
    Behne D, Pfiefer H, Rothlein D, et al. Cellular and subcellular distribution of selenium and selenoproteins. In: RousselAM, FavierA, AndersonRA, eds. Trace Elements in Man and Animals 10: Proceedings of the Tenth International Symposium on Trace Elements in Man and Animals. Evian, France: Plenum Press; 2000:2933.
  • 45
    Thomson CD, Robinson MF, Butler JA, et al. Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC in blood components of New Zealand women. Br J Nutr. 1993;69(2):577588.
  • 46
    Sunde RA. Selenium. In: O'DellBL, SundeRA, eds. Handbook of Nutritionally Essential Mineral Elements. New York: Marcel Dekker;1997:493556.
  • 47
    Arthur JR. The role of selenium in thyroid hormone metabolism. Can J Physiol Pharmacol. 1991;69(11):16481652.
  • 48
    Levander OA. Nutrition and newly emerging viral diseases: an overview. J Nutr. 1997;127(suppl 5):948S950S.
  • 49
    McKenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. Immunol Today. 1998;19(8):342345.
  • 50
    Allan CB, Lacourciere GM, Stadtman TC. Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr. 1999;19:116.
  • 51
    Diplock AT. Antioxidants and disease prevention. Mol Aspects Med. 1994;15(4):293376.
  • 52
    Grimble RF. Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz. 1994;2(2):175185.
  • 53
    Aaseth J, Haugen M, Forre O. Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst. 1998;123(1):36.
  • 54
    Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann N Y Acad Sci. 1990;587:123139.
  • 55
    Knekt P, Heliovaara M, Aho K, et al. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology. 2000;11(4):402405.
  • 56
    McCloy R. Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion. 1998;59(suppl 4):3648.
  • 57
    Shaheen SO, Sterne JA, Thompson RL, et al. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med. 2001;164(10, pt 1):18231828.
  • 58
    Kiremidjian-Schumacher L, Roy M, Wishe HI, et al. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res. 1994;41(1–2):115127.
  • 59
    Guimaraes MJ, Peterson D, Vicari A, et al. Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci U S A. 1996;93(26):1508615091.
  • 60
    Ferrans VJ, Rodriguez ER. The pathology of the cardiomyopathies. In: GilesTD, SanderGE, eds. Cardiomyopathy. Littleton, MA: PSG Publishing; 1988:1554.
  • 61
    Ge KY, Bai JJ, Xu DM, et al. The protective effect of selenium against viral myocarditis in mice. In: CombsGF, LevanderOA, SpallholzJE, et al, eds. Selenium in Biology and Medicine. New York, NY: Van Nostrand Reinhold;1987:761768.
  • 62
    Beck MA, Shi Q, Morris VC, et al. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med. 1995;1(5):433436.
  • 63
    Su C, Gong C, Li J, et al. Preliminary results of viral etiology of Keshan disease. Chin Med J. 1979;59:466472.
  • 64
    Johnson RA, Baker SS, Fallon JT, et al. An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med. 1981;304(20):12101212.
  • 65
    Fleming CR, Lie JT, McCall JT, et al. Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterology. 1982;83(3):689693.
  • 66
    van Rij AM, Thomson CD, McKenzie JM, et al. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr. 1979;32(10):20762085.
  • 67
    Yusuf SW, Rehman Q, Casscells W. Cardiomyopathy in association with selenium deficiency: a case report. JPEN J Parenter Enteral Nutr. 2002;26(1):6366.
  • 68
    Bialostosky K, Wright JD, Kennedy-Stephenson J, et al. Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States 1988–94. Vital Health Stat 11. 2002;(245):1158.
  • 69
    Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors. 1998;7(1–2):113174.
  • 70
    Ozer NK, Boscoboinik D, Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int. 1995;35(1):117124.
  • 71
    Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3(1):4247.
  • 72
    Lapenna D, de Gioia S, Ciofani G, et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation. 1998;97(19):19301934.
  • 73
    Sattler W, Maiorino M, Stocker R. Reduction of HDL- and LDL-associated cholesterylester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51). Arch Biochem Biophys. 1994;309(2):214221.
  • 74
    Kardinaal AF, Kok FJ, Kohlmeier L, et al. Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. Am J Epidemiol. 1997;145(4):373379.
  • 75
    Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis. 1992;96(1):3342.
  • 76
    Virtamo J, Valkeila E, Alfthan G, et al. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol. 1985;122(2):276282.
  • 77
    Shisler JL, Senkevich TG, Berry MJ, et al. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science. 1998;279(5347):102105.
  • 78
    Zhang W, Ramanathan CS, Nadimpalli RG, et al. Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol Trace Elem Res. 1999;70(2):97116.
  • 79
    Zhao L, Cox AG, Ruzicka JA, et al. Molecular modeling and in vitro activity of an HIV-1- encoded glutathione peroxidase. Proc Natl Acad Sci U S A. 2000;97(12):63566361.
  • 80
    Bock A, Forchhammer K, Heider J, et al. Selenocysteine: the 21st amino acid. Mol Microbiol. 1991;5(3):515520.
  • 81
    Berry MJ, Larsen PR. Recognition of UGA as a selenocysteine codon in eukaryotes: a review of recent progress. Biochem Soc Trans. 1993;21(4):827832.
  • 82
    Shen Q, Chu FF, Newburger PE. Sequences in the 3'-untranslated region of the human cellular glutathione peroxidase gene are necessary and sufficient for selenocysteine incorporation at the UGA codon. J Biol Chem. 1993;268(15):1146311469.
  • 83
    Berry MJ, Banu L, Harney JW, et al. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 1993;12(8):33153322.
  • 84
    Taylor EW, Ramanathan CS, Nadimpalli RG. In: WittenM, ed. Computational Medicine, Public Health and Biotechnology: Building a Man in the Machine Part 1. London, England: World Scientific; 1996:285309.
  • 85
    Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? FEBS Lett. 1989;251(1–2):17.
  • 86
    Senkevich TG, Bugert JJ, Sisler JR, et al. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science. 1996;273(5276):813816.
  • 87
    Buttke TM, Sandstrom PA. Redox regulation of programmed cell death in lymphocytes. Free Radic Res. 1995;22(5):389397.
  • 88
    Taylor EW, Nadimpalli RG, Ramanathan CS. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res. 1997;56(1):6391.